Koc-Kan Ho

734 total citations
17 papers, 476 citations indexed

About

Koc-Kan Ho is a scholar working on Molecular Biology, Organic Chemistry and Cancer Research. According to data from OpenAlex, Koc-Kan Ho has authored 17 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Organic Chemistry and 3 papers in Cancer Research. Recurrent topics in Koc-Kan Ho's work include Chemical Synthesis and Analysis (6 papers), Click Chemistry and Applications (4 papers) and Receptor Mechanisms and Signaling (4 papers). Koc-Kan Ho is often cited by papers focused on Chemical Synthesis and Analysis (6 papers), Click Chemistry and Applications (4 papers) and Receptor Mechanisms and Signaling (4 papers). Koc-Kan Ho collaborates with scholars based in United States, United Kingdom and China. Koc-Kan Ho's co-authors include Michael V. McCullar, K. Mark Parnell, Jason M. Foulks, Steven B. Kanner, Rebecca N. Nix, Thomas F. Hendrickson, Kevin M. Wright, K. Świerczek, Michael Saunders and Steven G. Kultgen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Koc-Kan Ho

16 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Koc-Kan Ho United States 12 328 82 73 64 44 17 476
Xiaohong Song China 12 364 1.1× 63 0.8× 107 1.5× 100 1.6× 12 0.3× 22 594
Ronald Grigg United Kingdom 10 255 0.8× 41 0.5× 108 1.5× 121 1.9× 121 2.8× 11 512
Afshin Bahador United States 10 314 1.0× 21 0.3× 43 0.6× 47 0.7× 33 0.8× 19 496
James J. Perkins United States 12 212 0.6× 34 0.4× 50 0.7× 176 2.8× 35 0.8× 19 483
Maria Hägg Sweden 7 378 1.2× 120 1.5× 155 2.1× 40 0.6× 10 0.2× 8 568
Siwei Li China 13 403 1.2× 129 1.6× 90 1.2× 28 0.4× 21 0.5× 25 556
Kenneth W. Batchelor United States 9 159 0.5× 25 0.3× 53 0.7× 48 0.8× 138 3.1× 12 442
Philipp Y. Maximov United States 17 293 0.9× 94 1.1× 204 2.8× 101 1.6× 421 9.6× 26 760
Stéphanie Jean United States 11 199 0.6× 69 0.8× 98 1.3× 17 0.3× 15 0.3× 21 498
Guiying Hong United States 12 400 1.2× 37 0.5× 28 0.4× 7 0.1× 22 0.5× 16 522

Countries citing papers authored by Koc-Kan Ho

Since Specialization
Citations

This map shows the geographic impact of Koc-Kan Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koc-Kan Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koc-Kan Ho more than expected).

Fields of papers citing papers by Koc-Kan Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koc-Kan Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koc-Kan Ho. The network helps show where Koc-Kan Ho may publish in the future.

Co-authorship network of co-authors of Koc-Kan Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Koc-Kan Ho. A scholar is included among the top collaborators of Koc-Kan Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koc-Kan Ho. Koc-Kan Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Deng, Jianjun, Haixia Yang, Jun Yang, et al.. (2021). Eicosanoid regulation of debris-stimulated metastasis. Proceedings of the National Academy of Sciences. 118(41). 21 indexed citations
2.
Parnell, K. Mark, Jason M. Foulks, Rebecca N. Nix, et al.. (2013). Pharmacologic Activation of PKM2 Slows Lung Tumor Xenograft Growth. Molecular Cancer Therapeutics. 12(8). 1453–1460. 55 indexed citations
3.
Foulks, Jason M., Bai Luo, K. Mark Parnell, et al.. (2013). Synthesis and structure–activity relationship of 2-arylamino-4-aryl-pyrimidines as potent PAK1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(14). 4072–4075. 14 indexed citations
4.
Xu, Yong, Xiaohui Liu, Michael A. Saunders, et al.. (2013). Discovery of 3-(trifluoromethyl)-1H-pyrazole-5-carboxamide activators of the M2 isoform of pyruvate kinase (PKM2). Bioorganic & Medicinal Chemistry Letters. 24(2). 515–519. 43 indexed citations
5.
Ho, Koc-Kan, K. Mark Parnell, Yi Yuan, et al.. (2012). Discovery of 4-phenyl-2-phenylaminopyridine based TNIK inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(2). 569–573. 23 indexed citations
6.
Foulks, Jason M., Michael Saunders, Xiaohui Liu, et al.. (2012). Abstract 3762: Second generation PIM inhibitors exhibit improved activity in solid tumor models. Cancer Research. 72(8_Supplement). 3762–3762. 1 indexed citations
7.
Foulks, Jason M., K. Mark Parnell, Rebecca N. Nix, et al.. (2011). Epigenetic Drug Discovery: Targeting DNA Methyltransferases. SLAS DISCOVERY. 17(1). 2–17. 117 indexed citations
8.
Li, Hong, Andrew G. Cole, Koc-Kan Ho, et al.. (2010). Identification and optimization of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V3 (V1b) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 20(18). 5394–5397. 3 indexed citations
9.
Olson, John S., Koc-Kan Ho, Jingchun Yang, et al.. (2010). Identification and hit-to-lead optimization of a novel class of CB1 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(18). 5449–5453. 3 indexed citations
10.
Lim, Herman D., Paolo Conti, Miranda M.C. van der Lee, et al.. (2009). Nonpeptidergic Allosteric Antagonists Differentially Bind to the CXCR2 Chemokine Receptor. Journal of Pharmacology and Experimental Therapeutics. 329(2). 783–790. 33 indexed citations
11.
Guo, Tao, Anton E.P. Adang, Roland E. Dolle, et al.. (2004). Small molecule biaryl FSH receptor agonists. Part 1. Bioorganic & Medicinal Chemistry Letters. 14(7). 1713–1716. 37 indexed citations
12.
Guo, Tao, Anton E.P. Adang, Peng Geng, et al.. (2004). Small molecule biaryl FSH receptor agonists. Part 2: Lead optimization via parallel synthesis. Bioorganic & Medicinal Chemistry Letters. 14(7). 1717–1720. 38 indexed citations
13.
Ho, Koc-Kan, Kenneth C. Appell, John J. Baldwin, et al.. (2003). 2-(Aminomethyl)-benzamide-based glycine transporter type-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(2). 545–548. 12 indexed citations
14.
Auld, Douglas S., David Diller, & Koc-Kan Ho. (2002). Targeting signal transduction with large combinatorial collections. Drug Discovery Today. 7(24). 1206–1213. 12 indexed citations
15.
Ho, Koc-Kan, et al.. (1997). Solution Phase Preparation of Highly Pure Amide Mixtures via In-Situ Chlorotrimethylsilane Protection and Activation. Synthetic Communications. 27(5). 883–895. 1 indexed citations
16.
Leone‐Bay, Andrea, Koc-Kan Ho, Rajesh Agarwal, et al.. (1996). 4-[4-[(2-Hydroxybenzoyl)amino]phenyl]butyric Acid as a Novel Oral Delivery Agent for Recombinant Human Growth Hormone. Journal of Medicinal Chemistry. 39(13). 2571–2578. 61 indexed citations
17.
Ho, Koc-Kan, et al.. (1996). A Practical Synthesis of ω-Aminoalkanoic Acid Derivatives from Cycloalkanones. Synthetic Communications. 26(14). 2641–2649. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026